Zanubrutinib-induced aseptic meningitis: a case report and literature review

Zanubrutinib is a Bruton tyrosine kinase (BTK) inhibitor used in B cell malignancy treatment and is generally well tolerated in most patients. Zanubrutinib-induced aseptic meningitis is currently not reported. Herein, we present the first case of zanubrutinib-induced aseptic meningitis. A 33-year-ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jinjun, Wang, Lian, Zhong, Xiao, Yang, Chenlu, Wu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505928/
https://www.ncbi.nlm.nih.gov/pubmed/37727390
http://dx.doi.org/10.3389/fphar.2023.1242491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505928/
https://www.ncbi.nlm.nih.gov/pubmed/37727390
http://dx.doi.org/10.3389/fphar.2023.1242491

Ejemplares similares